Abstract
Depression is one of the common mental illnesses. Because it is an important complication of diabetes, its association with changes in insulin levels and insulin resistance, the causative factors of diabetes, has attracted widespread attention. However, the association between insulin and depression has not been systematically studied through bibliometric and visual analysis. This study is based on 3131 publications of Web of Science to identify the current research status and research trends in this field. The results show that since 2010, the number of publications has been growing rapidly. Cooperative network analysis shows that the United States, the University of Toronto and Roger S Mcintyre are the most influential countries, research institutes and scholars, respectively. Insulin resistance, obesity, and metabolic syndrome are hot topics in this field. Analysis of keywords and references reveals that "sex hormones," is new research area that constantly emerging. As far as we know, this study is the first one to visualize the association between depression and insulin and predict potential future research trends through bibliometric and visual analysis.
Introduction
Depression and diabetes represent two of the most significant global health burdens, frequently presenting as comorbid conditions. Clinical observations indicate that individuals with diabetes are twice as likely to experience depression, suggesting a biological "bridge" between metabolic dysfunction and mood disorders. Despite extensive research, the field has lacked a systematic overview of how these two domains intersect. This bibliometric analysis maps a decade of research (2010–2020) to visualize the evolving landscape of the insulin-depression axis, identifying key contributors and emerging trends.
Methodology and Data
The study utilized bibliometric analysis, a quantitative approach to map patterns in scientific literature. Data were retrieved from the Web of Science Core Collection (WOSCC) using search terms related to "insulin" and "depression." The final dataset comprised 3,131 publications (articles and reviews) published in English between 2010 and 2020. Analysis was performed using CiteSpace (5.7.R4) to conduct co-occurrence, co-citation, and collaboration network mapping, alongside burstness detection to identify rapidly emerging topics.
Results and Discussion
Growth Trends in Research
The volume of research in this field has seen a steady and rapid increase over the last decade. Annual publications rose from approximately 195 in 2010 to 356 in 2020, reflecting the growing clinical and academic interest in the metabolic underpinnings of psychiatric disorders.
Global Collaboration Networks
The research landscape is characterized by strong international and inter-institutional collaboration. The United States emerged as the most influential country, acting as a central hub for global research. The University of Toronto stands out as the leading institution, while Roger S. McIntyre is identified as the most prolific author, particularly noted for his work on the metabolic-mood connection.
Thematic Shifts and Emerging Frontiers
The analysis reveals a significant paradigm shift from traditional monoamine-focused theories of depression toward integrated metabolic and endocrine frameworks. Key findings include:
- The Metabolic Syndrome Axis: Keywords such as "insulin resistance," "obesity," and "metabolic syndrome" dominate the literature, highlighting the focus on systemic metabolic health.
- Sex Hormones: A major emerging "hot spot" is the role of sex hormones (e.g., estrogen and testosterone) in mediating both insulin sensitivity and mood, particularly in conditions like Polycystic Ovary Syndrome (PCOS).
- Exercise as Intervention: Physical activity is frequently cited as a common denominator that effectively addresses both insulin resistance and depressive symptoms.
Conclusion and Future Directions
This study provides the first comprehensive visualization of the research linking insulin and depression. While the field has matured significantly, limitations remain, including a reliance on a single database and English-language publications. Future research is expected to delve deeper into the molecular mechanisms connecting sex hormones and insulin signaling to mood, with a focus on perinatal and menopausal health. The ultimate goal is the development of multi-target therapies that treat metabolic and psychiatric symptoms as a unified disorder.
Summary updated